About TriSalus Life Sciences Inc
- Industry: Biotechnology
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://trisaluslifesci.com/
Frequently Asked Questions
What is the 52-week range for TLSI?
The 52-week high is $7.95 and the 52-week low is $2.2.
What is the P/E ratio for TLSI?
The P/E ratio data is currently unavailable.
What is the dividend yield for TLSI?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -79.02%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -62.59%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 5.02.
Analyst Recommendation Trends
Wall Street analyst consensus for TLSI over the last few months:
Latest TLSI News
Unusual volume stocks in Thursday's session
Unusual volume stocks in Thursday's session
Crude Oil Gains 1%; Cintas Earnings Top Views
U.S. stocks fell Wednesday, led by a 1.1% Nasdaq drop. Cintas beat estimates and raised guidance; oil gained while gold, silver and copper declined.
TriSalus Secures FDA Clearance For TriNav Advance as Stock Tests Key Support
TriSalus Life Sciences secured FDA clearance for its TriNav Advance device, but shares face critical resistance levels amid a recent slide.
TriSalus Life Sciences Shares Rise 15.6% After FDA Clearance for TriNav Advance
TriSalus Life Sciences (NASDAQ:TLSI) shares rose 15. 6% in pre-market trading after the company announced that the U.
TriSalus Life Sciences, Lakefront Biotherapeutics, Editas Medicine And Other Big Stocks Moving Higher On Wednesday
U.S. stocks fell as Nasdaq dropped 100+ points, while TriSalus surged 5.8% on FDA clearance; Securitize, Lakefront and others also gained.
Microsoft To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Wednesday
Analysts raised targets for Meta, Microsoft, Valero and others; Microsoft upgraded to Buy, while KB Home and RTX targets fell.
Market-Moving News for September 23rd
IONQ: 14% | IonQ shares are trading higher after the company announced that researchers demonstrated the development and testing of the first end-to-end real-time quantum error correction decoder that runs on a single
HC Wainwright & Co. Maintains Buy on TriSalus Life Sciences, Raises Price Target to $12
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains TriSalus Life Sciences (NASDAQ:TLSI) with a Buy and raises the price target from $11 to $12.
Why Worthington Enterprises Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket
Worthington Enterprises surged 15.9% premarket after beating Q1 EPS and sales estimates; Wheeler REIT led gainers, while Jaguar Health and Biomea fell.
These stocks are moving in today's after hours session
The regular session of the US market on Tuesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
TriSalus Life Sciences Receives FDA Clearance for TriNav® Advance, Strengthening Comprehensive Pressure-Enabled Drug Delivery™ (PEDD™) Portfolio for Liver Embolization
WESTMINSTER, Colo., September 22, 2026--TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (the "Company"), an oncology company integrating novel delivery technology with standard-of-care therapies and its investigational immunotherapeutic to transform treatment for patients with solid tumors, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for TriNav® Advance, the newest addition to its Pressure-Enabled Drug Delivery™ (PEDD) portfolio.
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Jaguar Health (NASDAQ:JAGX) shares moved upwards by 32.2% to $45.56 during Tuesday's after-market session. The company's market cap stands at $1.1 million. Bullfrog AI Hldgs (NASDAQ:BFRG) shares
This Robinhood Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Analysts initiate coverage: Buy ratings for Robinhood ($170), TriSalus ($11), Kodiak AI ($8); Underperform for Deckers ($70).
HC Wainwright & Co. Initiates Coverage On TriSalus Life Sciences with Buy Rating, Announces Price Target of $11
HC Wainwright & Co. analyst Swayampakula Ramakanth initiates coverage on TriSalus Life Sciences (NASDAQ:TLSI) with a Buy rating and announces Price Target of $11.
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-07-01 | Patience David | -14,650 | $4.46 | $65,339 |
| 2026-06-30 | Marshak Richard | +561 | $3.87 | $2,171 |
| 2026-06-30 | Szela Mary T | +3,990 | $3.87 | $15,441 |
| 2026-05-15 | Marshak Richard | -543 | $2.67 | $1,450 |
| 2026-05-15 | Patience David | +7,100 | $2.43 | $17,253 |
| 2026-05-15 | Gordon Gary B. | +10,000 | $2.46 | $24,600 |
| 2026-05-15 | Wahlstrom Mats | +60,000 | $2.53 | $151,800 |
| 2026-05-15 | Stansky Michael P | +200,000 | $2.5 | $500,000 |
| 2026-05-15 | Stansky Michael P | +410,000 | $2.5 | $1,025,000 |
| 2026-05-15 | Szela Mary T | +39,682 | $2.59 | $102,776 |
| 2026-05-14 | Stansky Michael P | +47,003 | - | - |
| 2026-05-14 | Stansky Michael P | +20,089 | - | - |
| 2026-05-14 | Stansky Michael P | +23,501 | - | - |
| 2026-05-14 | Valle William | +56,403 | - | - |
| 2026-05-14 | Valle William | +24,553 | - | - |
| 2026-05-14 | Valle William | +28,201 | - | - |
| 2026-05-14 | Gordon Gary B. | +56,403 | - | - |
| 2026-05-14 | Gordon Gary B. | +24,553 | - | - |
| 2026-05-14 | Gordon Gary B. | +28,201 | - | - |
| 2026-05-14 | Wahlstrom Mats | +75,204 | - | - |
| 2026-05-14 | Wahlstrom Mats | +34,226 | - | - |
| 2026-05-14 | Wahlstrom Mats | +37,602 | - | - |
| 2026-05-14 | MATLIN DAVID J | +56,403 | - | - |
| 2026-05-14 | MATLIN DAVID J | +23,065 | - | - |
| 2026-05-14 | MATLIN DAVID J | +28,201 | - | - |
| 2026-05-14 | HICKS KERRY R | +56,403 | - | - |
| 2026-05-14 | HICKS KERRY R | +28,201 | - | - |
| 2026-03-17 | Szela Mary T | -15,944 | $3.85 | $61,384 |
| 2026-03-16 | Devlin Jodi | -273 | $4.12 | $1,125 |
| 2026-03-16 | Cox Bryan F. | -579 | $4.12 | $2,385 |
| 2026-03-16 | Marshak Richard | -419 | $4.12 | $1,726 |
| 2026-03-16 | Stevens Jennifer | -774 | $4.12 | $3,189 |
| 2026-03-12 | Devlin Jodi | -1,772 | $4.09 | $7,247 |
| 2026-03-12 | Cox Bryan F. | -1,467 | $4.09 | $6,000 |
| 2026-03-12 | Marshak Richard | -1,589 | $4.09 | $6,499 |
| 2026-03-12 | Stevens Jennifer | -1,552 | $4.09 | $6,348 |
| 2026-03-11 | Devlin Jodi | -1,162 | $4.13 | $4,799 |
| 2026-03-11 | Cox Bryan F. | -1,138 | $4.13 | $4,700 |
| 2026-03-11 | Marshak Richard | -1,449 | $4.13 | $5,984 |
| 2026-03-11 | Stevens Jennifer | -1,204 | $4.13 | $4,973 |
| 2026-03-11 | Szela Mary T | -4,358 | $4.13 | $17,999 |
| 2026-02-23 | Patience David | +3,657 | $4.1 | $14,994 |
| 2026-02-23 | Valle William | +30,487 | $4.1 | $124,997 |
| 2026-02-23 | Gordon Gary B. | +9,756 | $4.1 | $40,000 |
| 2026-02-23 | Stansky Michael P | +117,198 | $4.1 | $480,512 |
| 2026-02-23 | Stansky Michael P | +243,900 | $4.1 | $999,990 |
| 2026-02-23 | Szela Mary T | +30,487 | $4.1 | $124,997 |
| 2026-02-04 | Stansky Michael P | +92,537 | - | - |
| 2025-11-24 | Devlin Jodi | +100,000 | - | - |
| 2025-11-24 | Devlin Jodi | +50,000 | - | - |
| 2025-11-24 | Marshak Richard | +120,000 | - | - |
| 2025-11-24 | Marshak Richard | +60,000 | - | - |
| 2025-11-24 | Stevens Jennifer | +100,000 | - | - |
| 2025-11-24 | Stevens Jennifer | +50,000 | - | - |
| 2025-11-24 | Cox Bryan F. | +80,000 | - | - |
| 2025-11-24 | Cox Bryan F. | +40,000 | - | - |
| 2025-11-24 | Patience David | +130,000 | - | - |
| 2025-11-24 | Patience David | +65,000 | - | - |
| 2025-11-24 | Szela Mary T | +250,000 | - | - |
| 2025-11-24 | Szela Mary T | +300,000 | - | - |
| 2025-11-24 | Szela Mary T | +125,000 | - | - |